MDR Organisms Increase VAP Mortality 6-Fold

Ventilator-associated pneumonia caused by multidrug-resistant organisms was associated with a mortality rate six times higher than cases of VAP caused by non-MDR organisms, according to research published in the American Journal of Infection Control.

Advertisement

Researchers studied a 107-member patient population, 49 of whom contracted VAP.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Factors associated with MDR VAP were home antibiotics, pre-ventilator-associated pneumonia hospital stay and exposure to healthcare, according to the article.

More Articles on Infection Control & Clinical Quality:

NSAIDs May Fight Mutlidrug-Resistant Bugs

Simulation-Based Mastery Learning Curriculum Reduces CLABSI Rate

Hospital Harms More Deadly for Surgical Patients Than Other Inpatients

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.